Stress contributes to the etiology of addiction, but the mechanisms underlying this phenomenon are stillunknown. The endocannabinoids (eCBs) - anandamide and 2-arachidonoylglycerol (2-AG) - and theirattending cannabinoid (CB) receptors are thought to play important roles in the regulation of stress-copingbehaviors. Project 5 will examine whether changes in eCB signaling contribute to the neurobehavioralalterations induced by stress. We hypothesize that the eCB system enhances stress-coping responses byacting as a downstream regulator of corticotrophin-releasing factor (CRF), a neuropeptide implicated instress-related disorders. We have four specific aims: 1. To determine the effects of CRF on brain eCBmobilization. Initial results indicate that administration of CRF in rats alters brain eCB levels. We proposeto characterize this response by identifying the CRF receptor subtype(s) involved, their brain localization,and the biochemical mechanism through which they influence eCB mobilization. 2. To examine the roleof the eCB system in CRF-induced behaviors. Preliminary findings suggest that brain eCB mobilizationmodulates the neurobehavioral actions of CRF. To test this idea, we will examine whether agents thateither increase eCB levels (the anandamide degradation inhibitor URB597) or block CB receptors (theB! antagonist rimonabant) affect three actions of CRF that closely mimic those elicited by acute stress:inhibition of feeding, enhancement of anxiety-related behaviors and elevation of plasma corticosteronelevels. 3. To assess the contribution of the eCB system to stress-induced behaviors mediated byCRF. We will determine the effects of URB597 and rimonabant on three neurobehavioral outcomes ofacute restraint stress that are mediated by CRF: inhibition of feeding, enhancement of anxiety-relatedbehaviors and elevation of plasma corticosterone levels. Chronic exposure to stress disrupts behavior,reducing the ability to cope with normally manageable stressful stimuli. To test whether such disturbancesare due to a disruption in the normal balance between CRF and anandamide signaling in the brain, we will4. determine the impact of chronic stress on brain eCB signaling. To this end, we will (i) identify themolecular mechanisms underlying such alterations; and (ii) determine whether they are associated withchanges in CB1 receptor expression. The results of these studies should facilitate the development ofinnovative therapies for stress-related disorders such as addiction, anxiety and depression. Developmentof new therapies will be of great benefit to decreasing the public health costs related to addiction.
| Keereetaweep, Jantana; Chapman, Kent D (2016) Lipidomic Analysis of Endocannabinoid Signaling: Targeted Metabolite Identification and Quantification. Neural Plast 2016:2426398 |
| Holman, E Alison; Guijarro, Ana; Lim, James et al. (2014) Effects of acute stress on cardiac endocannabinoids, lipogenesis, and inflammation in rats. Psychosom Med 76:20-28 |
| DiPatrizio, Nicholas V; Astarita, Giuseppe; Schwartz, Gary et al. (2011) Endocannabinoid signal in the gut controls dietary fat intake. Proc Natl Acad Sci U S A 108:12904-8 |
| Astarita, Giuseppe; Geaga, Jennifer; Ahmed, Faizy et al. (2009) Targeted lipidomics as a tool to investigate endocannabinoid function. Int Rev Neurobiol 85:35-55 |
| Astarita, Giuseppe; Piomelli, Daniele (2009) Lipidomic analysis of endocannabinoid metabolism in biological samples. J Chromatogr B Analyt Technol Biomed Life Sci 877:2755-67 |
| Parker, L A; Limebeer, C L; Rock, E M et al. (2009) The FAAH inhibitor URB-597 interferes with cisplatin- and nicotine-induced vomiting in the Suncus murinus (house musk shrew). Physiol Behav 97:121-4 |
| Clapper, Jason R; Mangieri, Regina A; Piomelli, Daniele (2009) The endocannabinoid system as a target for the treatment of cannabis dependence. Neuropharmacology 56 Suppl 1:235-43 |
| Astarita, Giuseppe; Ahmed, Faizy; Piomelli, Daniele (2009) Lipidomic analysis of biological samples by liquid chromatography coupled to mass spectrometry. Methods Mol Biol 579:201-19 |
| Justinova, Zuzana; Mangieri, Regina A; Bortolato, Marco et al. (2008) Fatty acid amide hydrolase inhibition heightens anandamide signaling without producing reinforcing effects in primates. Biol Psychiatry 64:930-7 |
